 | Up a level |
Patsenker, Eleonora; Chicca, Andrea; Petrucci, Vanessa; Moghadamrad, Sheida; De Gottardi, Andrea; Hampe, Jochen; Gertsch, Jürg; Semmo, Nasser; Stickel, Felix (2017). 4-O'-methylhonokiol protects from alcohol/carbon tetrachloride-induced liver injury in mice. Journal of molecular medicine JMM, 95(10), pp. 1077-1089. Springer 10.1007/s00109-017-1556-y
Patsenker, Eleonora; Stoll, Matthias; Millonig, Gunda; Agaimy, Abbas; Wissniowski, Till; Schneider, Vreni; Mueller, Sebastian; Brenneisen, Rudolf; Seitz, Helmut K; Ocker, Matthias; Stickel, Felix (2011). Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. Molecular medicine, 17(11-12), pp. 1285-94. Manhasset, NY: Feinstein Institute for Medical Research 10.2119/molmed.2011.00149
Patsenker, Eleonora; Stickel, Felix (2011). Role of integrins in fibrosing liver diseases. American journal of physiology - gastrointestinal and liver physiology, 301(3), G425-34. Bethesda, Md.: American Physiological Society 10.1152/ajpgi.00050.2011
Gäbele, Erwin; Dostert, Karin; Dorn, Christoph; Patsenker, Eleonora; Stickel, Felix; Hellerbrand, Claus (2011). A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. Alcoholism: clinical and experimental research, 35(7), pp. 1361-7. Oxford: Wiley-Blackwell 10.1111/j.1530-0277.2011.01472.x
Patsenker, Eleonora; Schneider, Vreni; Ledermann, Monika; Saegesser, Hans; Dorn, Christoph; Hellerbrand, Claus; Stickel, Felix (2011). Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. Journal of hepatology, 55(2), pp. 388-98. Amsterdam: Elsevier 10.1016/j.jhep.2010.10.044
Stickel, Felix; Droz, Sara; Patsenker, Eleonora; Bögli-Stuber, Katja; Aebi, Beat; Leib, Stephen L. (2009). Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. Journal of hepatology, 50(1), pp. 111-117. Amsterdam: Elsevier 10.1016/j.jhep.2008.08.017
Patsenker, Eleonora; Popov, Yury; Stickel, Felix; Schneider, Vreni; Ledermann, Monika; Sägesser, Hans; Niedobitek, Gerald; Goodman, Simon L; Schuppan, Detlef (2009). Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology, 50(5), pp. 1501-11. Hoboken, N.J.: Wiley Interscience 10.1002/hep.23144
Wang, Ying; Millonig, Gunda; Nair, Jagadeesan; Patsenker, Eleonora; Stickel, Felix; Mueller, Sebastian; Bartsch, Helmut; Seitz, Helmut K (2009). Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology, 50(2), pp. 453-61. Hoboken, N.J.: Wiley Interscience 10.1002/hep.22978
Patsenker, Eleonora; Popov, Yury; Stickel, Felix; Jonczyk, Alfred; Goodman, Simon L; Schuppan, Detlef (2008). Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology, 135(2), pp. 660-70. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2008.04.009
Stickel, Felix; Osterreicher, Christoph H; Halangk, Juliane; Berg, Thomas; Homann, Nils; Hellerbrand, Claus; Patsenker, Eleonora; Schneider, Vreni; Kolb, Armin; Friess, Helmut; Schuppan, Detlef; Puhl, Gero; Seitz, Helmut K; Leathart, Julian L B; Day, Christopher P (2008). No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease. Alcoholism: clinical and experimental research, 32(6), pp. 959-65. Oxford: Wiley-Blackwell 10.1111/j.1530-0277.2008.00654.x
Osterreicher, Christoph H; Halangk, Juliane; Berg, Thomas; Patsenker, Eleonora; Homann, Nils; Hellerbrand, Claus; Seitz, Helmut K; Eurich, Dennis; Stickel, Felix (2008). Evaluation of the transforming growth factor beta1 codon 25 (Arg-->Pro) polymorphism in alcoholic liver disease. Cytokine, 42(1), pp. 18-23. Philadelphia, Pa.: Saunders 10.1016/j.cyto.2008.02.003
Popov, Yury; Patsenker, Eleonora; Stickel, Felix; Zaks, Jessica; Bhaskar, K Ramakrishnan; Niedobitek, Gerald; Kolb, Armin; Friess, Helmut; Schuppan, Detlef (2008). Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. Journal of hepatology, 48(3), pp. 453-64. Amsterdam: Elsevier 10.1016/j.jhep.2007.11.021
